Abstract: A method for electroplating low-resistance metal wire for resolving the problem to fabricate the metal wire on large-area substrate through the technology of photolithographing and etching in the prior art. Then the invention improves the RC-delay characteristic of circuit on large-area substrate and reduces the number of masks for processing of a structure of gate overlap lightly-doped drain (source) (GOLDD).

Abstract: The present invention provides therapeutic methods which employ one or more identifiable types of mammalian stem cells, and/or their progenitor progeny cells, and/or their lineage-committed descendant cells, and/or their partially-differentiated offspring cells—with or without completely differentiated cells—to treat living mammalian subjects afflicted with a clinically recognized form of cardiopathology. The identifiable cell types include embryonic stem cells and their offspring cells; as well as the presently identified types of adult stem cells and their various offspring cells; and also include recently identified alternative cell types which have functional stem cell properties. Among the clinical forms of cardiopathology which can be efficaciously treated using the present therapeutic methods are myocardial infarction, myocarditis, heart failure, and cardiac dysrhythmia.

Abstract: A solid hydrophobic surface wetted with an aqueous solution that includes a first and second surfactant. The first surfactant includes a first straight-chain, branched chain or cyclic hydrocarbon chain and a first hydrophilic moiety. The second surfactant includes a second straight-chain, branched chain or cyclic hydrocarbon chain and a second hydrophilic moiety. The first and second straight-chain, branched chain or cyclic hydrocarbon chains may or may not be the same; the first and second hydrophilic moieties are not the same; and the first surfactant is added to the second surfactant in an amount that causes a synergistic increase in the spreading factor on the hydrophobic surface.

Abstract: The present invention provides genetically altered mammalian embryonic stem cells, their living descendent progeny having an altered genomic DNA, and therapeutic methods using these cells for improving cardiac function in a living subject after myocardial infarction. The genetically altered embryonic stem and progenitor cells may be maintained in-vitro as a stable cell line; and transplanted as active, mitotic cells to an infarcted area of the myocardial using any surgical procedure. After transplantation at a chosen anatomic site within the heart of the subject, these genetically altered cells will differentiate in-site, cause a regeneration of myocardocytes, and will effect a marked improvement in cardiac function for the subject.

Abstract: The present invention is a method for markedly improving cardiac function and repairing heart tissue in a living mammalian subject after the occurrence of a myocardial infarction. The method is a surgical technique which introduces and implants mammalian embryonic stem cells into the infarcted area of the myocardium. After implantation, the embryonic stem cells form stable grafts and survive indefinitely within the infarcted area of the heart in the living host. The demonstrated beneficial effects of the method include a decreased infarcted area and improved cardiac function as assessed by hemodynamic and echocardiographic measurements.

Abstract: The present invention relates to a novel herbal composition having antimycotic activity effective against tinea infections, comprising plant substances as main ingredients, and method of treating a patient having a tinea infection. More particularly, the present invention relates to an antimycotic composition effective against tinea infections utilizing natural substances obtained from a combination of Angelicae Pubescentis Radix, Notopterygium Radix and Haliotis Diversicolor Reeve, and in some embodiments further comprising Pheretima Aspergillum (Perrier).